Surgery Partners Inc. Common Stock (SGRY)

FairStock Score: 58/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for a business that earns consistent profits and can be bought at a sensible price. Surgery Partners owns a network of ambulatory surgery centers and surgical hospitals, a business with real demand and $3.3 billion of revenue in FY2025, yet the bottom line has been elusive. In FY2025 it lost $77.9 million, after losing $168.1 million in FY2024 and $11.9 million in FY2023. In the quarter ended 2026-06-30, revenue was $848.9 million and net income was -$15.0 million, or -$0.12 per diluted share. That is not a record of durable earning power.

In plain English: Surgery Partners runs surgery centers and surgical hospitals in the U.S. It brings in billions in revenue and cash, but it has posted losses in each of the last four years, including a $15.0 million loss in the quarter ended June 30, 2026. At $14.55 on 2026-10-13, the price is near its accounting value, but the weak profits make it hard to call clearly cheap or expensive.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer